170 related articles for article (PubMed ID: 35888555)
1. The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review.
Liu X; Huang L; Liu M; Wang Z
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888555
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
[TBL] [Abstract][Full Text] [Related]
3. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
4. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
Ogino S; Brahmandam M; Cantor M; Namgyal C; Kawasaki T; Kirkner G; Meyerhardt JA; Loda M; Fuchs CS
Mod Pathol; 2006 Jan; 19(1):59-68. PubMed ID: 16118624
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component.
Wei Q; Wang X; Gao J; Li J; Li J; Qi C; Li Y; Li Z; Shen L
PLoS One; 2016; 11(6):e0156659. PubMed ID: 27300552
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.
Tajiri K; Sudou T; Fujita F; Hisaka T; Kinugasa T; Akagi Y
Anticancer Res; 2017 Jul; 37(7):3817-3823. PubMed ID: 28668881
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the molecular associations of mucinous colorectal cancer.
Reynolds IS; Furney SJ; Kay EW; McNamara DA; Prehn JHM; Burke JP
Br J Surg; 2019 May; 106(6):682-691. PubMed ID: 30945755
[TBL] [Abstract][Full Text] [Related]
10. Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.
Allart M; Leroy F; Kim S; Sefrioui D; Nayeri M; Zaanan A; Rousseau B; Ben Abdelghani M; de la Fouchardière C; Cacheux W; Legros R; Louafi S; Tougeron D; Bouché O; Fares N; Roquin G; Bignon AL; Maillet M; Pozet A; Hautefeuille V;
Dig Liver Dis; 2022 Mar; 54(3):391-399. PubMed ID: 34384712
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review.
An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
15. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum.
Kawabata Y; Tomita N; Monden T; Ohue M; Ohnishi T; Sasaki M; Sekimoto M; Sakita I; Tamaki Y; Takahashi J; Yagyu T; Mishima H; Kikkawa N; Monden M
Int J Cancer; 1999 Feb; 84(1):33-8. PubMed ID: 9988229
[TBL] [Abstract][Full Text] [Related]
17. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis.
Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes of colorectal cancers determined by PCR-based analysis.
Sugai T; Eizuka M; Takahashi Y; Fukagawa T; Habano W; Yamamoto E; Akasaka R; Otuska K; Matsumoto T; Suzuki H
Cancer Sci; 2017 Mar; 108(3):427-434. PubMed ID: 28083970
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
